NCT04704128View on ClinicalTrials.gov

Identification of Pathophysiological Pathways and Therapeutic Targets in Primary Stomatodynia by Salivary Metabolomics

CompletedOBSERVATIONAL
Enrollment

53

Participants

Timeline

Start Date

March 10, 2021

Primary Completion Date

May 12, 2021

Study Completion Date

May 12, 2021

Conditions
Primary Burning Mouth Syndrome
Interventions
OTHER

Salivic sample

Collection of total saliva not stimulated

Trial Locations (1)

37044

Department of Dermatology, Hospital University of Tours, Tours

All Listed Sponsors
lead

University Hospital, Tours

OTHER

NCT04704128 - Identification of Pathophysiological Pathways and Therapeutic Targets in Primary Stomatodynia by Salivary Metabolomics | Biotech Hunter | Biotech Hunter